Tazobactum%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520piperacillin

# Piperacillin/Tazobactam ## Overview Piperacillin/tazobactam is a combination antibiotic consisting of piperacillin, a penicillin-class broad-spectrum beta-lactam antibiotic, and tazobactam, a beta-lactamase inhibitor. This combination broadens the spectrum of activity of piperacillin to include many bacteria that produce beta-lactamase enzymes. It is typically administered intravenously. ## Primary Indications * Complicated intra-abdominal infections * Complicated skin and skin structure infections * Community-acquired pneumonia * Nosocomial pneumonia * Bacterial infections caused by piperacillin-susceptible organisms in combination with documented or suspected piperacillin-resistant monotherapy or combination therapy. ## Adult Dosing * **Standard dose:** 3.375 grams (3g piperacillin/0.375g tazobactam) every 6 hours. * **Higher dose:** 4.5 grams (4g piperacillin/0.5g tazobactam) every 6 or 8 hours. The choice of dose and frequency depends on the severity and type of infection, and local resistance patterns. * **Duration:** Typically 7 to 14 days, guided by clinical response and microbiology. ## Pediatric Dosing * **Ages > 2 months:** 93.75 mg/kg (80 mg piperacillin/13.75 mg tazobactam) every 8 hours, or 112.5 mg/kg (96 mg piperacillin/16.5 mg tazobactam) every 6 hours. * Dosing should not exceed the maximum adult dose of 4.5 grams per dose. * Dosing in neonates and infants < 2 months is not well established due to immature renal function and should be guided by institutional protocols. ## Dose Adjustments * **Renal Impairment (CrCl < 20 mL/min):** * 3.375g every 8 hours. * 4.5g every 8-12 hours. * **Hemodialysis:** Administer the recommended dose and an additional 0.75g dose after each dialysis session. * **Hepatic Impairment:** No dose adjustment generally needed. ## Contraindications * Hypersensitivity to piperacillin, tazobactam, or any component of the formulation. * History of a severe allergic reaction (e.g., anaphylaxis) to a beta-lactam antibiotic. ## Adverse Effects * **Common:** Diarrhea, nausea, vomiting, rash, headache, insomnia. * **Serious:** *Clostridioides difficile*-associated diarrhea, hypersensitivity reactions (including anaphylaxis), seizures (especially with high doses and renal impairment), neutropenia, thrombocytopenia, leukopenia, prolonged bleeding times, interstitial nephritis, hepatic enzyme elevations. ## Key Drug Interactions * **Probenecid:** Can increase and prolong piperacillin serum concentrations. * **Neuromuscular Blocking Agents (e.g., vecuronium):** Piperacillin may prolong the effect of vecuronium. * **Warfarin:** May decrease warfarin effect; monitor INR closely. * **Methotrexate:** Piperacillin may decrease methotrexate clearance; monitor methotrexate levels. ## Monitoring * Signs and symptoms of infection. * Renal function (serum creatinine, BUN). * Liver function tests (LFTs). * Complete blood count (CBC) with differential and platelet count. * Signs of hypersensitivity reactions. * Stool for *C. difficile* if diarrhea develops. ## Clinical Pearls * Tazobactam is a beta-lactamase inhibitor, extending the spectrum of piperacillin against many gram-negative bacteria producing beta-lactamases. * Dosing frequency is critical; 6-hour or 8-hour dosing depends on the specific regimen and indication. * Ensure adequate hydration to minimize the risk of crystalluria. * The potential for *C. difficile*-associated diarrhea should always be considered. * Monitor for signs of central nervous system toxicity, especially in patients with renal impairment. *** *This information is for educational purposes only and does not substitute for professional medical advice. Always consult the most current prescribing information and institutional guidelines before administering any medication.*